Clinical trial
Treatments for Psychogenic Nonepileptic Seizures (NES)
NCT00159965 · Rhode Island Hospital, Other · Completed
Key facts
| NCT number | NCT00159965 |
|---|---|
| Title | Treatments for Psychogenic Nonepileptic Seizures (NES) |
| Official title | Treatment for Psychogenic Nonepileptic Seizures: A Pilot, 12 Week, Prospective, Randomized, Placebo-controlled, Double-blind, Clinical Trial of Sertraline in the Treatment of Comorbid Psychiatric Disorders in NES |
| Acronym | NES |
| Lead sponsor | Rhode Island Hospital, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Convulsion, Non-Epileptic, Conversion Disorder, Depression, Stress Disorders, Post-Traumatic |
| Intervention type | Drug |
| Interventions | sertraline, placebo |
| Enrollment | 38 |
| Start date | Dec 1, 2003 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2009 |
| First posted | Sep 12, 2005 |
| Last update posted | Nov 20, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: